Press release
Alinia (Nitazoxanide) Market to Reach USD 84.6 Million by 2034
Alinia (Nitazoxanide)
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/63514
Key Takeaways
• Market Size (2024): USD 47.3 Million
• Forecast (2034): USD 84.6 Million
• CAGR (2025-2034): 6.1 %
• Key Segments: Indication, Formulation, Distribution Channel, and Region
• Major Companies: Romark Laboratories, Lupin Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Aurobindo Pharma, Cipla Ltd., and Glenmark Pharmaceuticals
Market Story
Alinia (Nitazoxanide) is a broad-spectrum antiprotozoal agent approved primarily for the treatment of Cryptosporidium and Giardia intestinalis infections. In recent years, it has gained scientific attention for its antiviral activity against influenza, rotavirus, and coronaviruses, significantly expanding its research footprint.
Rising gastrointestinal infection rates in developing regions, growing antimicrobial-resistance concerns, and the drug's proven safety profile have elevated its role in global public-health programs. Meanwhile, ongoing investigations into Nitazoxanide's immunomodulatory effects and potential in COVID-19 and hepatitis treatments are expected to expand its clinical utility over the forecast period.
Market Segmentation
By Indication: Protozoal Infections (Cryptosporidiosis, Giardiasis), Viral Infections (Influenza, Rotavirus, Others), Off-Label Uses
By Formulation: Tablets, Oral Suspension
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/63514/global-alinia-nitazoxanide-market
Recent Developments
• Romark Laboratories expanded Nitazoxanide distribution partnerships in Latin America and Southeast Asia to meet rising demand in pediatric diarrheal therapy.
• Lupin Pharmaceuticals initiated formulation enhancements for improved palatability and bioavailability in oral suspensions.
• Amneal Pharmaceuticals filed for FDA approval of a generic Nitazoxanide tablet in the United States.
• Cipla Ltd. collaborated with academic institutions to evaluate Nitazoxanide's antiviral potential against emerging respiratory pathogens.
• Aurobindo Pharma ramped up export production capacity to cater to markets in Africa and the Middle East.
Expert Insight
"Nitazoxanide's broad-spectrum efficacy and favorable safety record make it a strong candidate in both infectious-disease treatment and future antiviral development. Its repositioning potential could redefine antiparasitic drug economics,"
- Lead Analyst, Exactitude Consultancy
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=63514
Market Drivers
• Rising Prevalence of Protozoal Infections: Particularly in low- and middle-income countries with limited sanitation infrastructure.
• Expanded Clinical Research: Evaluation of Nitazoxanide for viral infections including influenza and COVID-19.
• Generic Penetration: Increasing affordability through regional manufacturing and biosimilar availability.
• Government Health Initiatives: WHO-backed parasitic-disease eradication programs and inclusion in essential-drug lists.
Forecast & Regional Insights
North America dominates the market with over 35 % share (2024) due to strong regulatory presence and established awareness programs. Asia Pacific is projected to record the fastest CAGR of 7.5 %, driven by high infection rates in India and Southeast Asia and expanding domestic production. Latin America remains a key growth frontier given supportive drug-procurement initiatives and improved healthcare infrastructure.
Conclusion
The Global Alinia (Nitazoxanide) Market is poised for steady expansion as antimicrobial stewardship, generic competition, and R&D diversification converge. With increasing relevance in both parasitic and viral disease management, Nitazoxanide continues to bridge critical therapeutic gaps in global infectious-disease control.
This report is also available in the following languages : Japanese (アリニア(ニタゾキサニド)), Korean (알리니아(니타족사나이드)), Chinese (Alinia(硝唑尼特)), French (Alinia (nitazoxanide)), German (Alinia (Nitazoxanid)), and Italian (Alinia (nitazoxanide)), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/63514/global-alinia-nitazoxanide-market#request-a-sample
Related Reports
Deal size of alinia between Romark and Chugai Market
https://exactitudeconsultancy.com/reports/67235/deal-size-of-alinia-between-romark-and-chugai-market
Clear Aligner Material Market
https://exactitudeconsultancy.com/reports/62077/global-clear-aligner-material-market
Digital Dentistry Devices Market
https://exactitudeconsultancy.com/reports/62453/global-digital-dentistry-devices-market
Alginate Impression Materials Market
https://exactitudeconsultancy.com/reports/62976/global-alginate-impression-materials-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alinia (Nitazoxanide) Market to Reach USD 84.6 Million by 2034 here
News-ID: 4259427 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Nitazoxanid
Alinia (nitazoxanide) Market Future Business Scope Analysis Report, Marketing St …
"As of 2024, the global market for Alinia (nitazoxanide) is valued at approximately $450 million. This market is projected to experience significant growth, reaching an estimated $850 million by 2034, reflecting a Compound Annual Growth Rate (CAGR) of around 6.6% during the forecast period from 2025 to 2034."
Exactitude Consultancy., Ltd. released a research report titled "Alinia (nitazoxanide) Market". This report covers the global Alinia (nitazoxanide) market sales, sales volume, price,…
Alinia (nitazoxanide) Market Estimated to Experience a Hike in Growth by 2034
The Alinia Market Is Set To Grow At An Estimated CAGR Of 6.5% From 2025 To 2034, Rising From $550 Million In 2024 To $1.042 Billion By 2034.
On March 24, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Alinia (nitazoxanide) market goods. The market study excludes key regions that are accelerating marketization. This section also…
